Retail & Wholesale » Retail | Pharma Foods International Co. Ltd.

Pharma Foods International Co. Ltd. | Cash Flow

Fiscal year is August-July. All values JPY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
293,488.00
11,688.00
184,497.00
28,706.00
123,871.00
313,650
Depreciation, Depletion & Amortization
24,762.00
24,872.00
30,303.00
43,369.00
76,163.00
89,142
Other Funds
-
-
-
3,857.00
-
70,632
Funds from Operations
236,892.00
6,153.00
436,931.00
83,789.00
216,501.00
332,164
Changes in Working Capital
220,129.00
224,653.00
194,819.00
119,087.00
17,352.00
83,379
Net Operating Cash Flow
16,763.00
218,500.00
242,112.00
35,298.00
233,853.00
415,543
Capital Expenditures
8,640.00
12,500.00
39,618.00
71,114.00
45,925.00
Sale of Fixed Assets & Businesses
144.00
-
370.00
-
-
Purchase/Sale of Investments
634,436.00
166,516.00
244,574.00
61,043.00
61,787.00
Net Investing Cash Flow
547,501.00
181,840.00
188,511.00
46,850.00
382,459.00
Issuance/Reduction of Debt, Net
797.00
200,797.00
797.00
678,876.00
905,533.00
Net Financing Cash Flow
202.00
699,332.00
29,644.00
685,233.00
903,958.00
Net Change in Cash
608,161.00
310,728.00
5,292.00
592,726.00
759,847.00
Free Cash Flow
8,235.00
229,308.00
280,730.00
74,875.00
210,785.00
Net Assets from Acquisitions
-
-
-
-
361,615.00
Other Sources
55,648.00
48,004.00
21,264.00
-
-
Change in Capital Stock
999.00
900,129.00
30,441.00
2,500.00
-
Exchange Rate Effect
43,695.00
11,736.00
18,665.00
10,359.00
4,495.00
Other Uses
134,087.00
50,828.00
38,079.00
36,779.00
36,705.00

About Pharma Foods International Co.

View Profile
Address
1-49 Goryo Ohara
Kyoto Kyoto 615
Japan
Employees -
Website http://www.pharmafoods.co.jp
Updated 07/08/2019
Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. It operates through the following business segments: Functional Materials, Mail Order, and Biomedical. The Functional Materials segment provides egg yolk antibodies (IgY), folic acid eggs, gamma-aminobutyric acid (GABA), Bonepep and others.